In a new report, researchers from Mount Sinai School of Medicine have found a gene that may be involved in the link between Type 2 diabetes and Alzheimer’s disease. Previous research has found that healthy elderly people with Type 2 diabetes are twice as likely to develop Alzheimer’s disease, but …
Read More »Yearly Archives: 2009
Zinc Intake Linked to Lower Risk for Type 2 Diabetes
The study results suggest that a diet with high zinc-to-heme iron ratio is significantly associated with lower risk of Type 2 diabetes.
Read More »Cost-Effective for Management of Type 2 Diabetes: Bariatric Surgery
Induced weight loss by surgery is cost-effective relative to conventional therapy for the management of Type 2 diabetes in obese patients, both in the short term and projected over a patient’s lifetime. And the return on investment of surgical therapy is fully recovered through
Read More »Intensive Therapy Compromises Regulatory Response to Hypoglycemia in Diabetics
According to a recent study, both intensive oral combination therapy and antecedent hypoglycemia blunt the body’s physiological defenses against later hypoglycemia in people with Type 2 diabetes.
Read More »Severe Hypoglycemia Associated with Increased Risk of Dementia for Older Adults with Type 2 Diabetes
Having hypoglycemic (low blood sugar level) episodes that are severe enough to require hospitalization are associated with a greater risk of dementia for older adults with Type 2 diabetes, according to a study.
Read More »Exenatide Vs. Sitagliptin feature
Effects of Exenatide versus Sitagliptin on Postprandial Glucose, Insulin, and Glucagon Secretion, Gastric Emptying, and Caloric Intake: A Randomized, Crossover Study
Read More »The Next DPP-4 Inhibitor Onglyza™ Passes CVD Review: Coming Soon
An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to
Read More »Liraglutide Has Low CVD Risk but May Be Blocked for Approval
Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of
Read More »On-Demand Care for Diabetics May Not Help
Diabetic adults using same-day medical scheduling to manage their care fared no better and, in some aspects, saw their condition worsen, compared with those who
Read More »What Is a Normal A1c for Type 2 Children?
According to the ADA and AACE, a normal A1c result is from 4-6%. Yet we know the closer you get to 6% means your average blood glucose is getting higher and increases your risk for pre-diabetes and diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.